Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

For those who are looking into using a weight loss drug, how fast they work often comes into question. While the timeline for ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Misleading ads on social media are promoting products that doctors say are not effective but mimic the names of more ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

A YOUNG woman went from a size 18 to a 10 after using fat jabs, but has experienced 10 less than ideal side effects.  Bethany Diana, 27, lost six stone in just nine months after using ...

Hims Hers Health Inc (NYSE:HIMS), a telehealth firm known for offering consumer-focused digital healthcare, is reducing its headcount by more than 4% as part of a pivot in its business strategy, ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...